Proteochemometrics – recent developments in bioactivity and selectivity modeling

Drug Discovery Today: Technologies - Tập 32 - Trang 89-98 - 2019
Brandon J. Bongers1, Adriaan. P. IJzerman1, Gerard J.P. Van Westen1
1Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, P.O. Box 9502, 2300 RA, Leiden, The Netherlands

Tài liệu tham khảo

Lapinsh, 2001, Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions, Biochim Biophys Acta - Gen Subj, 1525, 180, 10.1016/S0304-4165(00)00187-2 van Westen, 2011, Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets, Medchemcomm, 2, 16, 10.1039/C0MD00165A Van Westen, 2013, Benchmarking of protein descriptor sets in proteochemometric modeling (part 1): comparative study of 13 amino acid descriptor sets, J Cheminform, 5, 41, 10.1186/1758-2946-5-41 Van Westen, 2013, Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets, J Cheminform, 5, 42, 10.1186/1758-2946-5-42 Baumann, 2014, Reliable estimation of prediction errors for QSAR models under model uncertainty using double cross-validation, J Cheminform, 6, 1, 10.1186/s13321-014-0047-1 Corté S-Ciriano, 2016, Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel, Bioinformatics, 32, 85, 10.1093/bioinformatics/btv529 Lapinsh, 2005, Improved approach for proteochemometrics modeling: application to organic compound-amine G protein-coupled receptor interactions, Bioinformatics, 21, 4289, 10.1093/bioinformatics/bti703 Lenselink, 2017, Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set, J Cheminform, 9, 45, 10.1186/s13321-017-0232-0 Giblin, 2018, Prospectively validated proteochemometric models for the prediction of small-molecule binding to bromodomain proteins, J Chem Inf Model, 58, 1870, 10.1021/acs.jcim.8b00400 Subramanian, 2017, 3D proteochemometrics: using three-dimensional information of proteins and ligands to address aspects of the selectivity of serine proteases, Medchemcomm, 8, 1037, 10.1039/C6MD00701E Cortes-Ciriano, 2015, Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling, J Cheminform, 7, 1, 10.1186/s13321-014-0049-z Zheng, 2013, Collaborative matrix factorization with multiple similarities for predicting drug-target interactions, Proc. ACM SIGKDD Int. Conf. Knowl. Discov. Data Min., vol. Part F1288, 1025, 10.1145/2487575.2487670 Simm, 2018, Repurposing high-throughput image assays enables biological activity prediction for drug discovery, Cell Chem Biol, 25, 10.1016/j.chembiol.2018.01.015 Zhang, 2017, Computational drug repositioning using collaborative filtering via multi-source fusion, Expert Syst Appl, 84, 281, 10.1016/j.eswa.2017.05.004 Rifaioglu, 2020, DEEPScreen: high performance drug-target interaction prediction with convolutional neural networks using 2-D structural compound representations, Chem Sci, 11, 2531, 10.1039/C9SC03414E Lapins, 2010, Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques, BMC Bioinformatics, 11, 1, 10.1186/1471-2105-11-339 Gao, 2013, Study on human GPCR-inhibitor interactions by proteochemometric modeling, Gene, 518, 124, 10.1016/j.gene.2012.11.061 Lee, 2019, Multi-channel PINN: investigating scalable and transferable neural networks for drug discovery, J Cheminform, 11, 1, 10.1186/s13321-019-0368-1 Cortés-Ciriano, 2015 Demiriz, 2001, Support vector machine regression in chemometrics, Comput Sci Stat Proc 33RD Symp Interface Scott, 2013, Merits of random forests emerge in evaluation of chemometric classifiers by external validation, Anal Chim Acta, 801, 22, 10.1016/j.aca.2013.09.027 Liu, 2010, Applying chemometrics approaches to model and predict the binding affinities between the human amphiphysin SH3 domain and its peptide ligands (suplementary material), Protein Pept Lett, 17, 246, 10.2174/092986610790226085 Lindström, 2009, Quantitative protein descriptors for secondary structure characterization and protein classification, Chemom Intell Lab Syst, 95, 74, 10.1016/j.chemolab.2008.08.006 Nazarshodeh, 2018, A novel proteochemometrics model for predicting the inhibition of nine carbonic anhydrase isoforms based on supervised Laplacian score and k-nearest neighbour regression, SAR QSAR Environ Res, 29, 419, 10.1080/1062936X.2018.1447995 Shar, 2016, Pred-binding: large-scale protein–ligand binding affinity prediction, J Enzyme Inhib Med Chem, 31, 1443, 10.3109/14756366.2016.1144594 Yordanov, 2018, Proteochemometrics-based prediction of peptide binding to HLA-DP proteins, J Chem Inf Model, 58, 297, 10.1021/acs.jcim.7b00026 Dimitrov, 2015, Peptide binding prediction to five most frequent HLA-DQ proteins – a proteochemometric approach, Mol Inform, 34, 467, 10.1002/minf.201400150 Yordanov, 2017, vol. 64 Cortés-Ciriano, 2015, Prediction of PARP inhibition with proteochemometric modelling and conformal prediction, Mol Inform, 34, 357, 10.1002/minf.201400165 Rasti, 2018, Proteochemometric modeling of the origin of thymidylate synthase inhibition, Chem Biol Drug Des, 91, 1007, 10.1111/cbdd.13163 Rasti, 2017, Exploring the origin of phosphodiesterase inhibition: via proteochemometric modeling, RSC Adv, 7, 28056, 10.1039/C7RA02332D Hariri, 2019, Probing the origin of dihydrofolate reductase inhibition via proteochemometric modeling, J Chemom, 33, e3090, 10.1002/cem.3090 Hariri, 2020, Structural insights into the origin of phosphoinositide 3-kinase inhibition, Struct Chem, 1 Sorgenfrei, 2018, Kinome-wide profiling prediction of small molecules, ChemMedChem, 13, 495, 10.1002/cmdc.201700180 Christmann-Franck, 2016, Unprecedently large-scale kinase inhibitor set enabling the accurate prediction of compound-kinase activities: a way toward selective promiscuity by design?, J Chem Inf Model, 56, 1654, 10.1021/acs.jcim.6b00122 Rasti, 2016, Quantitative characterization of the interaction space of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII, and XIV and their inhibitors, using the proteochemometric approach, Chem Biol Drug Des, 88, 341, 10.1111/cbdd.12759 Manoharan, 2015, Target specific proteochemometric model development for BACE1 – protein flexibility and structural water are critical in virtual screening, Mol Biosyst, 11, 1955, 10.1039/C5MB00088B Tresadern, 2017, Identification of allosteric modulators of metabotropic glutamate 7 receptor using proteochemometric modeling, J Chem Inf Model, 57, 2976, 10.1021/acs.jcim.7b00338 Qiu, 2018, Finding the molecular scaffold of nuclear receptor inhibitors through high-throughput screening based on proteochemometric modelling, J Cheminform, 10, 21, 10.1186/s13321-018-0275-x Simeon, 2016, Origin of aromatase inhibitory activity via proteochemometric modeling, PeerJ, 2016, e1979, 10.7717/peerj.1979 Paricharak, 2015, Proteochemometric modelling coupled to in silico target prediction: an integrated approach for the simultaneous prediction of polypharmacology and binding affinity/potency of small molecules, J Cheminform, 7, 15, 10.1186/s13321-015-0063-9 Burggraaff, 2019, Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling, J Cheminform, 11, 1, 10.1186/s13321-019-0337-8 Shaikh, 2016, An improved approach for predicting drug–target interaction: proteochemometrics to molecular docking, Mol Biosyst, 12, 1006, 10.1039/C5MB00650C Aliper, 2016, Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data, Mol Pharm, 13, 2524, 10.1021/acs.molpharmaceut.6b00248 Zakharov, 2019, Novel consensus architecture to improve performance of large-scale multitask deep learning QSAR models, J Chem Inf Model, 59, 4613, 10.1021/acs.jcim.9b00526 Reker, 2017, Active learning for computational chemogenomics, Future Med Chem, 9, 381, 10.4155/fmc-2016-0197 Kim, 2020 Jaeger, 2018, Mol2vec: unsupervised machine learning approach with chemical intuition, J Chem Inf Model, 58, 27, 10.1021/acs.jcim.7b00616 Jiménez, 2018, KDEEP: protein-ligand absolute binding affinity prediction via 3D-convolutional neural networks, J Chem Inf Model, 58, 287, 10.1021/acs.jcim.7b00650 Playe, 2020, Evaluation of deep and shallow learning methods in chemogenomics for the prediction of drugs specificity, J Cheminform, 12, 1, 10.1186/s13321-020-0413-0 Öztürk, 2018, DeepDTA: deep drug-target binding affinity prediction, Bioinformatics, vol. 34, i821, 10.1093/bioinformatics/bty593 Lopez-Del Rio, 2019, Evaluation of cross-validation strategies in sequence-based binding prediction using deep learning, J Chem Inf Model, 59, 1645, 10.1021/acs.jcim.8b00663 Yang, 2018, Learned protein embeddings for machine learning, Bioinformatics, 34, 2642, 10.1093/bioinformatics/bty178 Alley, 2019, Unified rational protein engineering with sequence-based deep representation learning, Nat Methods, 16, 1315, 10.1038/s41592-019-0598-1